Literature DB >> 25567791

Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments.

Virginia G Wadley1, Leslie A McClure, David G Warnock, Caroline L Lassen-Greene, Robert J Hopkin, Dawn A Laney, Virginia M Clarke, Manjula Kurella Tamura, George Howard, Katherine Sims.   

Abstract

We examined the feasibility of recruiting US adults ≥45 years old with Fabry disease (FD) for telephone assessments of cognitive functioning. A case-control design matched each FD participant on age, sex, race, and education to four participants from a population-based study. Fifty-four participants with FD age 46-72 years were matched to 216 controls. Standardized cognitive assessments, quality of life (QOL), and medical histories were obtained by phone, supplemented by objective indices of comorbidities. Normalized scores on six cognitive tasks were calculated. On the individual tasks, scores on list recall and semantic fluency were significantly lower among FD participants (p-values < 0.05), while scores on the other four tasks did not differ. After averaging each participant's normalized scores to form a cognitive composite, we examined group differences in composite scores, before and after adjusting for multiple covariates using generalized estimating equations. The composite scores of FD cases were marginally lower than controls before covariate adjustments (p = 0.08). QOL and mental health variables substantially attenuated this finding (p = 0.75), highlighting the influence of these factors on cognition in FD. Additional adjustment for cardiovascular comorbidities, kidney function, and stroke had negligible impact, despite higher prevalence in the FD sample. Telephone-based cognitive assessment methods are feasible among adults with FD, affording access to a geographically dispersed sample. Although decrements in discrete cognitive domains were observed, the overall cognitive function of older adults with FD was equivalent to that of well-matched controls before and after accounting for multiple confounding variables.

Entities:  

Year:  2015        PMID: 25567791      PMCID: PMC4361921          DOI: 10.1007/8904_2014_346

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  27 in total

1.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

2.  Incident cognitive impairment is elevated in the stroke belt: the REGARDS study.

Authors:  Virginia G Wadley; Frederick W Unverzagt; Lisa C McGuire; Claudia S Moy; Rodney Go; Brett Kissela; Leslie A McClure; Michael Crowe; Virginia J Howard; George Howard
Journal:  Ann Neurol       Date:  2011-05-26       Impact factor: 10.422

3.  Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study.

Authors:  Perri Segal; Yoav Kohn; Yehuda Pollak; Gheona Altarescu; Esti Galili-Weisstub; Annick Raas-Rothschild
Journal:  J Inherit Metab Dis       Date:  2010-06-15       Impact factor: 4.982

4.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

5.  Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.

Authors:  M Ries; H J Kim; C K Zalewski; M A Mastroianni; D F Moore; R O Brady; J M Dambrosia; R Schiffmann; C C Brewer
Journal:  Brain       Date:  2006-11-14       Impact factor: 13.501

6.  Depression in adults with Fabry disease: a common and under-diagnosed problem.

Authors:  A L Cole; P J Lee; D A Hughes; P B Deegan; S Waldek; R H Lachmann
Journal:  J Inherit Metab Dis       Date:  2007-11-12       Impact factor: 4.982

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

Review 8.  The cerebral vasculopathy of Fabry disease.

Authors:  David F Moore; Christine R Kaneski; Hasan Askari; Raphael Schiffmann
Journal:  J Neurol Sci       Date:  2007-03-23       Impact factor: 3.181

9.  Cognitive testing in Fabry disease: pilot using a brief computerized assessment tool.

Authors:  Deborah Elstein; Glen M Doniger; Gheona Altarescu
Journal:  Isr Med Assoc J       Date:  2012-10       Impact factor: 0.892

10.  Neurology of Fabry disease.

Authors:  M Low; K Nicholls; N Tubridy; P Hand; D Velakoulis; L Kiers; P Mitchell; G Becker
Journal:  Intern Med J       Date:  2007-07       Impact factor: 2.048

View more
  2 in total

1.  Cognitive Impairments and Subjective Cognitive Complaints in Fabry Disease: A Nationwide Study and Review of the Literature.

Authors:  Josefine Loeb; Ulla Feldt-Rasmussen; Christoffer Valdorff Madsen; Asmus Vogel
Journal:  JIMD Rep       Date:  2018-04-14

Review 2.  Cognitive Assessment via Telephone: A Scoping Review of Instruments.

Authors:  Anne R Carlew; Hudaisa Fatima; Julia R Livingstone; Caitlin Reese; Laura Lacritz; Cody Pendergrass; Kenneth Chase Bailey; Chase Presley; Ben Mokhtari; Colin Munro Cullum
Journal:  Arch Clin Neuropsychol       Date:  2020-11-19       Impact factor: 2.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.